23 February 2012 News Archive
Short items, March 2012
Over £65 million has been awarded by the Engineering and Physical Sciences Research Council and the Technology Strategy Board to seven business-led projects aimed at developing therapeutic and diagnostic technologies that use nanotechnology. The aim is to make the UK an early competitive adopter of these technologies as well as supporting the commercialisation of ideas at their early stages.
This investment is part of a two stage initiative under the Nanoscience Through Engineering to Application Grand Challenge for Healthcare and the projects will be led by Critical Pharmaceuticals, Johnson Matthey, Mologic, Nanomerics, OJ-Bio, Renishaw Diagnostics and Sharp Laboratories of Europe.
12 June 2013 Research
Simple method for identifying incorrect structures of organic molecules due to NMR misassignments
17 June 2013 News and Analysis
Thinktank says hundreds of millions of pounds of tax breaks are going to city business firms and would be better spent elsewh...
14 June 2013 Research
Chemical mapping could help unpick the biology of extinct animals